Showing results (221-230 of 255) with videos related to
Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2020
Local Intracerebral Immunomodulation Using Interleukin-Expressing Mesenchymal Stem Cells in GlioblastomaMalte Mohme, Cecile L Maire, Ulf Geumann, et al.British Journal of Cancer|October 8, 2011
Low ANXA10 expression is associated with disease aggressiveness in bladder cancerP P Munksgaard, F Mansilla, A-S Brems Eskildsen, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2019
Alpha-1 Antitrypsin-Expressing Mesenchymal Stromal Cells Confer a Long-Term Survival Benefit in a Mouse Model of Lethal GvHDSabine Geiger, Emrah I Ozay, Ulf Geumann, et al.Neuroimage. Clinical|April 21, 2024
The connection of motor improvement after deep brain stimulation in Parkinson's disease and microstructural integrity of the substantia nigra and subthalamic nucleusMarco G Hermann, Nils Schröter, Alexander Rau, et al.Human Mutation|August 22, 2015
Targeted Resequencing of 29 Candidate Genes and Mouse Expression Studies Implicate ZIC3 and FOXF1 in Human VATER/VACTERL AssociationAlina C Hilger, Jan Halbritter, Tracie Pennimpede, et al.The Analyst|December 24, 2019
Morpho-molecular ex vivo detection and grading of non-muscle-invasive bladder cancer using forward imaging probe based multimodal optical coherence tomography and Raman spectroscopyFabian Placzek, Eliana Cordero Bautista, Simon Kretschmer, et al.Bioorganic & Medicinal Chemistry|February 13, 2010
Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agentsWen Cai, Mary Hassani, Rajesh Karki, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2022
External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell CancerBhavna Oza, Tim Eisen, Eleni Frangou, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020
Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup TrialTim Eisen, Eleni Frangou, Bhavna Oza, et al.Annals of the Rheumatic Diseases|January 16, 2016
Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working groupRobert G W Lambert, Pauline A C Bakker, Désirée van der Heijde, et al.Pageof 26